Literature DB >> 16876520

Melatonin concentrations in aqueous humor of glaucoma patients.

Christophe Chiquet1, Bruno Claustrat, Gilles Thuret, Jocelyne Brun, Howard M Cooper, Philippe Denis.   

Abstract

PURPOSE: To determine whether glaucoma patients exhibit an abnormal melatonin concentration in aqueous humor.
DESIGN: Case-controlled study, laboratory investigation.
METHODS: Aqueous humor and plasma samples of 28 patients with primary open-angle glaucoma and 31 nonglaucoma control patients were collected during surgery, and additional plasma samples were taken the night preceding surgery. Melatonin concentrations were determined using direct radioimmunoassay.
RESULTS: This study shows detectable concentrations of melatonin in the aqueous humor of healthy humans (45% of subjects) and of glaucoma patients (36% of subjects) sampled in the morning, with similar levels of aqueous humor melatonin concentrations in both groups (6.4 +/- 9.3 standard deviation (SD) pg/ml and 3.6 +/- 1.9 pg/ml, respectively). We find no significant association between the severity of glaucoma and melatonin levels in aqueous humor or in plasma.
CONCLUSIONS: Moderate and severe glaucoma does not appear to be associated with abnormal melatonin concentrations in aqueous humor, at least during the morning sampling period assayed in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876520     DOI: 10.1016/j.ajo.2006.03.040

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus.

Authors:  Erdinc Aydin; Semsettin Sahin
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

2.  Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.

Authors:  Wei Chen; Hui Cao; Qian-Yi Lu; Na Wang; Shu-Zhi Zhao; Xun Xu; Zhi Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells.

Authors:  Deniz Marangoz; Elif Guzel; Signem Eyuboglu; Asli Gumusel; Ismail Seckin; Ferda Ciftci; Bayram Yilmaz; Ilgaz Yalvac
Journal:  Int Ophthalmol       Date:  2017-11-20       Impact factor: 2.031

Review 4.  Is the melatonin receptor type 1 involved in the pathogenesis of glaucoma?

Authors:  Gianluca Tosini; Michael Iuvone; Jeffrey H Boatright
Journal:  J Glaucoma       Date:  2013 Jun-Jul       Impact factor: 2.503

5.  TRPV4 Stimulation Induced Melatonin Secretion by Increasing Arylalkymine N-acetyltransferase (AANAT) Protein Level.

Authors:  Hanan Awad Alkozi; Maria J Perez de Lara; Juan Sánchez-Naves; Jesús Pintor
Journal:  Int J Mol Sci       Date:  2017-04-01       Impact factor: 5.923

6.  Melatonin Attenuates LPS-Induced Proinflammatory Cytokine Response and Lipogenesis in Human Meibomian Gland Epithelial Cells via MAPK/NF-κB Pathway.

Authors:  Ren Liu; Jing Li; Yue Xu; Ziyan Chen; Huijing Ye; Jinhui Tang; Lai Wei; Lingyi Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

7.  Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.

Authors:  Richard Rosen; Dan-Ning Hu; Violete Perez; Katy Tai; Guo-Pei Yu; Min Chen; Paul Tone; Steven A McCormick; Joseph Walsh
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

8.  Changes in melatonin receptor expression in a murine model of glaucoma.

Authors:  Alejandro Martínez-Águila; Begoña Fonseca; María J Pérez de Lara; M Teresa Miras-Portugal; Rosa Gómez-Villafuertes; Gonzalo Carracedo; Jesús Pintor
Journal:  Mol Vis       Date:  2020-07-29       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.